...
首页> 外文期刊>Clinical otolaryngology: official journal of ENT-UK ; official journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery >Dexamethasone reduces pain, vomiting and overall complications following tonsillectomy in adults: a systematic review and meta-analysis of randomised controlled trials.
【24h】

Dexamethasone reduces pain, vomiting and overall complications following tonsillectomy in adults: a systematic review and meta-analysis of randomised controlled trials.

机译:地塞米松可减轻成人扁桃体切除术后的疼痛,呕吐和总体并发症:随机对照试验的系统评价和荟萃分析。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: Tonsillectomy is one of the most common surgical procedures, but there is debate whether systemic steroids should be used to reduce pain and post-operative complications. OBJECTIVE OF REVIEW: To determine whether peri-operative steroids reduce post-tonsillectomy pain and complications in adults. TYPE OF REVIEW: Systematic review and meta-analysis of randomised controlled trials. SEARCH STRATEGY: We searched MEDLINE (1950-2010), EMBASE (1980-2010), CINAHL (1981-2010), Web of Science, ProQuest, metaRegister, Conference Proceedings Citation Index, the Cochrane Library and reference lists of relevant studies. EVALUATION METHOD: Two reviewers independently selected trials and extracted data on their quality, characteristics and results. Trials included adults (age >16 years) undergoing elective tonsillectomy where peri-operative steroids were used, and the results were compared with control or placebo. RESULTS: There were seven randomised controlled trials (580 patients) reporting post-operative pain. Meta-analysis demonstrates that dexamethasone in adults reduces the pain level experienced in the first post-tonsillectomy day [standard mean difference (SMD): -0.63, 95% CI: -1.13 to -0.12] with significant heterogeneity (I(2) = 84%, P < 0.00001). Sub-group analysis to explore heterogeneity demonstrated this reduction in pain was mostly with high total dose steroids (total >10 mg over first 24 h post-operatively; SMD: -1.48, 95% CI: -2.17 to -0.79, P < 0.00001), especially when given both intra-operatively and post-operatively. There was no significant effect with low doses (SMD: -0.12, 95% CI: -0.36 to 0.13, P = 0.35). There were three trials (231 patients) that reported post-operative nausea and vomiting, three other trials (270 patients) reporting on bleeding and three trials (401 patients) reporting other complications (infections and odynophagia). There was a significant reduction in post-operative nausea and vomiting (RR: 0.53, 95% CI: 0.36 to 0.80, P = 0.002, I(2) = 26%) and bleeding (RR: 0.45, 95% CI: 0.25 to 0.80, P = 0.007, I(2) = 0%), but the reduction in the other complications did not reach statistical significance (RR: 0.69, 95% CI: 0.48 to 1.01, P = 0.06, I(2) = 0%). Pooling of these complications (post-operative nausea and vomiting, bleeding, infections and odynophagia) shows that in six trials (501 patients), the use of dexamethasone significantly reduced post-operative complications following tonsillectomy in adults (RR: 0.59, 95% CI: 0.49 to 0.71, P < 0.00001, I(2) = 0%), when compared with placebo or control. CONCLUSIONS: Dexamethasone reduces pain, post-operative nausea and vomiting, bleeding and overall post-operative complications in adults undergoing tonsillectomy. However, the effect of the dose of dexamethasone on post-operative pain and whether dexamethasone reduces bleeding require further research.
机译:背景:扁桃体切除术是最常见的手术方法之一,但是否应使用全身性类固醇激素来减轻疼痛和术后并发症仍存在争议。审查的目的:确定围手术期的类固醇是否可以减轻成人扁桃体切除术后的疼痛和并发症。评价类型:随机对照试验的系统评价和荟萃分析。搜索策略:我们搜索了MEDLINE(1950-2010年),EMBASE(1980-2010年),CINAHL(1981-2010年),Web of Science,ProQuest,metaRegister,会议录引文索引,Cochrane库和相关研究的参考文献清单。评估方法:两位审稿人独立选择试验并提取其质量,特征和结果的数据。试验包括接受选择性扁桃体切除术(使用围手术期使用类固醇)的成年人(年龄> 16岁),并将结果与​​对照或安慰剂进行比较。结果:有七项随机对照试验(580例患者)报告了术后疼痛。荟萃分析表明,成人地塞米松可以减轻扁桃体切除术后第一天的疼痛程度[标准平均差异(SMD):-0.63,95%CI:-1.13至-0.12],且异质性显着(I(2)= 84%,P <0.00001)。为探讨异质性而进行的亚组分析表明,疼痛的减轻主要是由于使用了高剂量的类固醇(术后最初24小时总计> 10 mg; SMD:-1.48,95%CI:-2.17至-0.79,P <0.00001 ),尤其是在术中和术后同时使用时。低剂量无明显影响(SMD:-0.12,95%CI:-0.36至0.13,P = 0.35)。有三项试验(231名患者)报告了术后恶心和呕吐,另外三项试验(270例患者)报告了出血,三项试验(401例患者)报告了其他并发症(感染和吞咽痛)。术后恶心和呕吐(RR:0.53,95%CI:0.36至0.80,P = 0.002,I(2)= 26%)和出血(RR:0.45,95%CI:0.25至0.5 0.80,P = 0.007,I(2)= 0%),但其他并发症的减少没有统计学意义(RR:0.69,95%CI:0.48至1.01,P = 0.06,I(2)= 0 %)。综合考虑这些并发症(术后恶心,呕吐,出血,感染和吞咽痛),在六项试验(501例患者)中,使用地塞米松可显着减少成人扁桃体切除术后的并发症(RR:0.59,95%CI) :与安慰剂或对照组比较时为0.49至0.71,P <0.00001,I(2)= 0%)。结论:地塞米松减轻了扁桃体切除术成人的疼痛,术后恶心和呕吐,出血和术后总体并发症。然而,地塞米松剂量对术后疼痛的影响以及地塞米松是否可减少出血需要进一步研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号